| Nomenclature | CB1 receptor | CB2 receptor |
| HGNC, UniProt | CNR1, P21554 | CNR2, P34972 |
| Principal transduction | Gi/o | Gi/o |
| (Sub)family-selective agonists (pKi) | CP55940 550, Δ9-tetrahydrocannabinol 550, HU-210 530, WIN55212-2 550 | CP55940 550, Δ9-tetrahydrocannabinol 550, HU-210 530, WIN55212-2 550 |
| Selective agonists (pKi) | arachidonyl-2-chloroethylamide (8.9 - Rat) 533, arachidonylcyclopropylamide (8.7 - Rat) 533, O-1812 (8.5 - Rat) 528, R-(+)-methanandamide (7.7 - Rat) 537 | JWH-133 (8.5) 535,541, AM1241 (8.1) 555, L-759,633 (7.7 – 8.2) 531,548, L-759,656 (7.7 – 7.9) 531,548, HU-308 (7.6) 532 |
| Selective antagonists (pKi) | rimonabant (7.9 – 8.7) 529,530,545,549,550, AM251 (8.1 - Rat) 539, AM281 (7.9 - Rat) 538, LY320135 (6.9) 529 | SR144528 (8.3 – 9.2) 546,548, AM630 (7.5) 548 |
| Radioligands (Kd) | [3H]rimonabant (Antagonist) (1x10−10 – 1.2x10−9 M - Rat) 527,534,536,543,547,551,554 | – |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.